NCT03480191View on ClinicalTrials.gov

Adjunction of Daptomycin for the Treatment of Pneumococcal Meningitis

PHASE2CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

June 7, 2018

Primary Completion Date

May 11, 2024

Study Completion Date

August 21, 2024

Conditions
Pneumococcal Meningitis
Interventions
DRUG

Daptomycin

Daptomycin will be given by intravenous infusion and administered over a 30 minutes infusion, daily, for 8 days and at the dosis of 10mg/kg/day.

Trial Locations (1)

21000

CHU Dijon Bourgogne, Dijon

All Listed Sponsors
lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT03480191 - Adjunction of Daptomycin for the Treatment of Pneumococcal Meningitis | Biotech Hunter | Biotech Hunter